Hauschild A - Search Results

1

Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.

Hauschild A, Gogas H, Tarhini A, Middleton MR, Testori A, Dréno B, Kirkwood JM. Hauschild A, et al. Cancer. 2008 Mar 1;112(5):982-94. doi: 10.1002/cncr.23251. Cancer. 2008. PMID: 18236459 Free article. Review.

2

Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis.

Hauschild A, Weichenthal M, Balda BR, Becker JC, Wolff HH, Tilgen W, Schulte KW, Ring J, Schadendorf D, Lischner S, Burg G, Dummer R. Hauschild A, et al. J Clin Oncol. 2003 Aug 1;21(15):2883-8. doi: 10.1200/JCO.2003.07.116. J Clin Oncol. 2003. PMID: 12885805 Clinical Trial.

3

Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma.

Wollina U, Dummer R, Brockmeyer NH, Konrad H, Busch JO, Kaatz M, Knopf B, Koch HJ, Hauschild A. Wollina U, et al. Among authors: hauschild a. Cancer. 2003 Sep 1;98(5):993-1001. doi: 10.1002/cncr.11593. Cancer. 2003. PMID: 12942567 Free article. Clinical Trial.

4

Individualized therapy of disseminated cancer using malignant melanoma as a model.

Hauschild A, Egberts F, Russo P, Kähler KC. Hauschild A, et al. Cancer Metastasis Rev. 2006 Jun;25(2):253-6. doi: 10.1007/s10555-006-8505-5. Cancer Metastasis Rev. 2006. PMID: 16770537 Review.

5

Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risks for the fetus?

Egberts F, Lischner S, Russo P, Kampen WU, Hauschild A. Egberts F, et al. Among authors: hauschild a. J Dtsch Dermatol Ges. 2006 Sep;4(9):717-20. doi: 10.1111/j.1610-0387.2006.06055.x. J Dtsch Dermatol Ges. 2006. PMID: 16928239 Review. English, German.

6

Molecularly targeted therapy for melanoma: current reality and future options.

Becker JC, Kirkwood JM, Agarwala SS, Dummer R, Schrama D, Hauschild A. Becker JC, et al. Among authors: hauschild a. Cancer. 2006 Nov 15;107(10):2317-27. doi: 10.1002/cncr.22273. Cancer. 2006. PMID: 17039502 Free article. Review.

7

Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha.

Satzger I, Meier A, Schenck F, Kapp A, Hauschild A, Gutzmer R. Satzger I, et al. Among authors: hauschild a. Int J Cancer. 2007 Dec 1;121(11):2562-6. doi: 10.1002/ijc.22951. Int J Cancer. 2007. PMID: 17680564 Free article.

8

New promises in the adjuvant, and palliative treatment of melanoma.

Hauschild A, Schadendorf D, Garbe C, Ugurel S, Kähler KC. Hauschild A, et al. Cancer Treat Res. 2007;135:277-92. doi: 10.1007/978-0-387-69219-7_20. Cancer Treat Res. 2007. PMID: 17953423 Review. No abstract available.

9

An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma.

Dummer R, Hauschild A, Becker JC, Grob JJ, Schadendorf D, Tebbs V, Skalsky J, Kaehler KC, Moosbauer S, Clark R, Meng TC, Urosevic M. Dummer R, et al. Among authors: hauschild a. Clin Cancer Res. 2008 Feb 1;14(3):856-64. doi: 10.1158/1078-0432.CCR-07-1938. Clin Cancer Res. 2008. PMID: 18245549 Free article. Clinical Trial.

10

Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Garbe C, et al. Among authors: hauschild a. Melanoma Res. 2008 Apr;18(2):152-60. doi: 10.1097/CMR.0b013e3282f702bf. Melanoma Res. 2008. PMID: 18337653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

572 results

Search Page